Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.
Mychaleckyj JC, Craven T, Nayak U, Buse J, Crouse JR, Elam M, Kirchner K, Lorber D, Marcovina S, Sivitz W, Sperl-Hillen J, Bonds DE, Ginsberg HN.
Mychaleckyj JC, et al.
Diabetes Care. 2012 May;35(5):1008-14. doi: 10.2337/dc11-1811. Epub 2012 Mar 19.
Diabetes Care. 2012.
PMID: 22432114
Free PMC article.
Clinical Trial.